Friday, December 28, 2012 8:30:21 AM
Key Investment Considerations:
Maintaining Speculative Buy rating. Increasing (12-month) price target to $5.45 from $5.00 per share due to
improved sector valuation.
Profit growth will be driven by gross margin gains stemming from the purchase of a royalty agreement, high
margin simulation software sales, and funded collaborations, which carry a gross margin of over 86%.
Use of software tools and analytics for drug discovery and development is becoming more widespread within
the pharmaceutical and biotechnology industries due to reduced R&D budgets.
SLP has penetrated only 10% of the 1,000+ potential pharmaceutical and biotechnology customers, leaving
ample revenue upside. Toxicology products, release of MembranePlus™ in FY13, and development of a new
chemical entity molecular library could underlie further revenue upside into FY14.
4Q12 income from continuing operations (reported 11-19-12) was $349,000 or $0.02 per share, up from $170,000 or
$0.01 last year, on a 14.9% sales increase to $1.6 million. 4Q12 sales and EPS were in line with our forecast.
Reduced our FY13 EPS projection by $0.03 to $0.19 on sales of $10.3 million (down $500,000). We anticipate
20 fewer new customers (60), a larger scientific team (3), and laboratory experiment expenses for development
of a second new chemical entity that was unanticipated earlier.
In FY14, we project 12.5% sales growth to $11.5 million and EPS of $0.23 per share. After four years of stable
pricing, we anticipate a price increase on software offerings, traction gains by MembranePlus, and a total of
70 (new) customers, up from 60 in FY13 and 43 in FY12.
Full report here:
http://www.taglichbrothers.com/TaglichTrack/Reports/simplus/simplus-12102012.pdf
Recent SLP News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:45:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:11:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:09:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:29:04 PM
- Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/28/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 12:00:21 PM
- Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions • Business Wire • 08/23/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/08/2024 06:18:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:25:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:24:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:22:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:19:09 PM
- Simulations Plus Releases DILIsym® X • Business Wire • 08/01/2024 12:30:00 PM
- Simulations Plus Releases ADMET Predictor® Version 12 • Business Wire • 07/30/2024 12:30:00 PM
- Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum • Business Wire • 07/25/2024 12:30:00 PM
- Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety • Business Wire • 07/11/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/08/2024 12:56:32 PM
- Apple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More News • IH Market News • 07/03/2024 10:59:39 AM
- Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results • Business Wire • 07/02/2024 08:06:00 PM
- Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit • Business Wire • 06/20/2024 12:30:00 PM
- Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date • Business Wire • 06/18/2024 12:30:00 PM
- QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus • Business Wire • 06/12/2024 12:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 12:00:28 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM